Inhibitory Antibodies
-
F1859 Anti-TIM-3/HAVCR2/CD366 Antibody (Surzebiclimab)Summary: Anti-TIM-3/HAVCR2/CD366 Antibody (Surzebiclimab) -
F1860 Anti-TNFalpha & IL-17 Antibody (ABT122)Summary: Anti-TNFalpha & IL-17 Antibody (ABT122) -
F1861 Anti-TNFRSF18/GITR/CD357 Antibody (Korea Natl.Cancer Ctr. patent anti-GITR)Summary: Anti-TNFRSF18/GITR/CD357 Antibody (Korea Natl.Cancer Ctr. patent anti-GITR) -
F1862 Anti-TNFRSF5/CD40 Antibody (Emory U. anti-CD40)Summary: Anti-TNFRSF5/CD40 Antibody (Emory U. anti-CD40) -
F1863 Anti-TNFRSF7/CD27 Antibody (Organon patent anti-CD27)Summary: Anti-TNFRSF7/CD27 Antibody (Organon patent anti-CD27) -
F1864 Anti-TNFSF2/TNFa Antibody (Licaminlimab)Summary: Anti-TNFSF2/TNFa Antibody (Licaminlimab) -
F1865 Anti-TNFSF2/TNFa Antibody (CDP571)Summary: Anti-TNFSF2/TNFa Antibody (CDP571) -
F1866 Anti-TNFSF2/TNFa Antibody (Epitomics patent anti-TNFα)Summary: Anti-TNFSF2/TNFa Antibody (Epitomics patent anti-TNFα) -
F1867 Anti-TNFSF7/CD27L/CD70 Antibody (Vorsetuzumab)Summary: Anti-TNFSF7/CD27L/CD70 Antibody (Vorsetuzumab) -
F1868 Anti-TPBG Antibody (ASN004)Summary: Anti-TPBG Antibody (ASN004)

